Cell Therapies Competitors and Similar CompaniesClear all
Cimeio's competitors and similar companies include Precigen and Mediphage Bioceuticals.
 Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. |  Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. |  Mediphage Bioceuticals Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform. | |
Founding Date | Founding Date 2020 | Founding Date 1998 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Basel, CH HQ | Locations Germantown, US HQ Gent, BE Sioux Center, US | Locations Toronto, CA HQ |
Employees | Employees 21 | Employees 601 | Employees 1023% decrease |
Funding | |||
Latest funding round | Latest funding round $ 50m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 3.5m (over 7 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 379m | Total funding raised $ 4.1m |
For sources of this data, please see the company profile
View Company Profiles
Precigen
HQ
Germantown, US
Employees
601
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
View companyMediphage Bioceuticals
HQ
Toronto, CA
Employees
10↓ 23% decrease
Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.
View company